skip to main
|
skip to sidebar
Alzheimers Drugs
Wednesday, December 2, 2009
Bayer Starts Phase III Trial With Florbetaben
Bayer Schering Pharma AG, Germany, is surpassing with the growth of florbetaben to await Alzheimer diagnosis...
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Related Sites
Health Care Equities
Senior Psychiatry
Followers
Blog Archive
►
2010
(20)
►
February
(5)
►
January
(15)
▼
2009
(29)
▼
December
(26)
Alzheimer's And Cancer Rarely Strike Together, Study
Diabetes Insight Could Lead to Better Treatments
Significantly Worse Outcomes In Cancer Patients Wi...
Imaging Test Detects Alzheimer's Disease That Is L...
Critical Communication For Caregivers
Nanotherapeutics Acquires Two Late Stage Clinical ...
University Of Florida To Lead National Effort To H...
More Leptin May Mean Less Alzheimer's
JAMA Editorial: Time For A New View Of Late-life D...
Alzheimer's Society Comment On The Second Reading ...
A Scaffold Regulating Protein Disposal Identified ...
Delayed Ageing Linked To Alzheimer's In Mice
Extended Youthfulness As A Prevention For Alzheime...
Delaying The Aging Process Protects Against Alzhei...
Potential New Target Found for Alzheimer's Disease
Butler Hospital Neurologist Lead Author Of Ground ...
HIV-related Memory Loss Linked To Alzheimer's Protein
New 1.5 M For Dementia Research Launched By Alzhei...
HIV Related Memory Loss Linked To Alzheimer's Protein
New Therapy Targets For Amyloid Disease
Reversing Abnormal Brain Activity In Alzheimer Mod...
Ginkgo Biloba Doesn't Prevent Heart Attack
Exercise May Lead to a Smarter, More Successful You
Alzheimer's Society Restructures To Meet Growing D...
Depression
Bayer Starts Phase III Trial With Florbetaben
►
November
(3)
About Me
Senior Talk
View my complete profile
No comments:
Post a Comment